Skip to main content
. Author manuscript; available in PMC: 2021 Jul 9.
Published in final edited form as: J Med Chem. 2020 Jun 17;63(13):7211–7225. doi: 10.1021/acs.jmedchem.0c00463

Figure 4.

Figure 4.

The effects of toremifene and the new 4-(aminomethyl)benzamides 49 and 32 on the infectivity of Y517S and T519V mutants of HIV/EBOV-GP pseudovirus in 293T cells. Functional activities of representative compounds (a) indoline 49; and (b) adamantyl substituted 4-(aminomethyl)benzamide 32. Toremifene was used as a reference compound (EC50 = 62.8 nM).